The antibacterial activity and mechanisms of Trp-containing peptides against multidrug-resistant Pseudomonas aeruginosa persisters

被引:1
|
作者
Li, Mengmiao [1 ,2 ]
Sun, Xiaomi [1 ]
Zhao, Lei [1 ]
Du, Wanying [1 ]
Shang, Dejing [1 ,2 ]
机构
[1] Liaoning Normal Univ, Sch Life Sci, Dalian, Peoples R China
[2] Liaoning Normal Univ, Liaoning Prov Key Lab Biotechnol & Drug Discovery, Dalian 116081, Peoples R China
基金
中国国家自然科学基金;
关键词
Antimicrobial peptide; Persisters; Membrane disruption; Oxidative stress; ANTIMICROBIAL PEPTIDES; POLYMYXIN-B; MEMBRANE; CELLS; BIOFILMS; STRAINS;
D O I
10.1016/j.biochi.2024.05.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bacterial persisters avoid antibiotic-mediated death by entering a dormant state and are considered a major cause of antibiotic treatment failure. Antimicrobial peptides (AMPs) with membrane-disrupting activity are promising drugs to eradicate persister cells. In this study, carbonyl cyanide m-chlorophenylhydrazone (CCCP), cipro floxacin (CIP), and rifampicin (RFP) were applied to induce the formation of multidrug-resistant Pseudomonas aeruginosa (MRPA0108) persisters, and the antibacterial activity and mechanisms of I1W and L12W (two Trp-containing peptides designed in our lab) against MRPA0108 persisters were investigated. The results showed that I1W and L12W displayed potent antibacterial activity against MRPA0108 persisters. Both Trp-containing peptides disturbed the inner and outer membrane of MRPA0108 persisters. In addition, I1W and L12W revealed novel antibacterial mechanisms by decreasing the enzymatic activities of superoxide dismutase (SOD) and catalase (CAT), increasing reactive oxygen species (ROS) and malondialdehyde (MDA) levels, consequently leading to oxidative stress. The transcriptome pro file of I1W-treated MRPA0108 persisters revealed that the genes involved in carbon metabolism, biosynthesis of amino acids, and the TCA cycle were downregulated, indicating that I1W interfered with metabolism and energy synthesis processes. Furthermore, both Trp-containing peptides displayed synergistic activities with antibiotic tobramycin and showed additive activities with cefepime or cipro floxacin, which revealed a potential therapeutic strategy for the eradication of MRPA0108 persisters. (c) 2024 Elsevier B.V. and Soci & eacute;t & eacute; Fran & ccedil;aise de Biochimie et Biologie Mol & eacute;culaire (SFBBM). All rights are reserved, including those for text and data mining, AI training, and similar technologies.
引用
收藏
页码:133 / 145
页数:13
相关论文
共 50 条
  • [21] Carbapenem-resistance mechanisms of multidrug-resistant Pseudomonas aeruginosa
    Fuste, Ester
    Lopez-Jimenez, Lidia
    Segura, Concha
    Gainza, Eusebio
    Vinuesa, Teresa
    Vinas, Miguel
    JOURNAL OF MEDICAL MICROBIOLOGY, 2013, 62 : 1317 - 1325
  • [22] In Vitro Antibacterial Experiment of Fuzheng Jiedu Huayu Decoction Against Multidrug-Resistant Pseudomonas aeruginosa
    Xu, Hongri
    Liu, Chang
    Li, Meng
    Wang, Chengxiang
    Liu, Guoxing
    Wang, Honghong
    Ma, Jie
    Li, Lei
    Chen, Meng
    Cheng, Miao
    Yao, Xingwei
    Lin, Ying
    Zhao, Shitong
    Wang, Yuting
    Wang, Mingzhe
    FRONTIERS IN PHARMACOLOGY, 2020, 10
  • [23] Biologically synthesized silver nanoparticles as potent antibacterial effective against multidrug-resistant Pseudomonas aeruginosa
    Campo-Beleno, C.
    Villamizar-Gallardo, R. A.
    Lopez-Jacome, L. E.
    Gonzalez, E. E.
    Munoz-Carranza, S.
    Franco, B.
    Morales-Espinosa, R.
    Coria-Jimenez, R.
    Franco-Cendejas, R.
    Hernandez-Duran, M.
    Lara-Martinez, R.
    Jimenez-Garcia, L. F.
    Fernandez-Presas, A. M.
    Garcia-Contreras, R.
    LETTERS IN APPLIED MICROBIOLOGY, 2022, 75 (03) : 680 - 688
  • [24] Antimicrobial effects of drugs against multidrug-resistant Pseudomonas aeruginosa
    Maeda, Kumiko
    Kobayashi, Youko
    Oie, Shigeharu
    Ishida, Shiro
    Okano, Yoshiro
    Kobayashi, Toshihiko
    Shikichi, Kyoko
    Mizuno, Hidekazu
    Kamiya, Akira
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) : 1898 - 1901
  • [25] Antimicrobial Peptides against Multidrug-Resistant Pseudomonas aeruginosa Biofilm from Cystic Fibrosis Patients
    Ben Hur, Daniel
    Kapach, Gal
    Wani, Naiem Ahmad
    Kiper, Edo
    Ashkenazi, Moshe
    Smollan, Gill
    Keller, Natan
    Efrati, Ori
    Shai, Yechiel
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (13) : 9050 - 9062
  • [26] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Hu, Yi-Fan
    Liu, Chang-Pan
    Wang, Nai-Yu
    Shih, Shou-Chuan
    BMC INFECTIOUS DISEASES, 2016, 16
  • [27] In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
    Yi-Fan Hu
    Chang-Pan Liu
    Nai-Yu Wang
    Shou-Chuan Shih
    BMC Infectious Diseases, 16
  • [28] In Vitro Hollow-Fiber Studies Assessing Antibacterial Activity of Ceftolozane/Tazobactam Against Multidrug-Resistant Pseudomonas Aeruginosa
    Carr, Donna
    Zhang, Zufei
    Si, Qian
    Racine, Fred
    Xiao, Jing Chen
    Katwaru, Ravi
    Wismer, Michael K.
    Johnson, Matthew G.
    Feng, Hwa-Ping
    Young, Katherine
    Rizk, Matthew L.
    Motyl, Mary
    OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (11):
  • [29] Bactericidal Activity in Filtrated Supernatant of Streptococcus Sanguinis against Multidrug-Resistant Pseudomonas Aeruginosa
    Watanabe, Kiwao
    Senba, Masachika
    Ichinose, Akitoyo
    Yamamoto, Takeshi
    Ariyoshi, Koya
    Matsumoto, Keizo
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 219 (02): : 79 - 84
  • [30] COMPARISON OF THE IN VITRO ACTIVITY OF MEROPENEM AND DORIPENEM AGAINST PSEUDOMONAS AERUGINOSA AND MULTIDRUG-RESISTANT ENTEROBACTERIACEAE
    Van Gasse, N.
    Vermeiren, S.
    Jeurissen, A.
    ACTA CLINICA BELGICA, 2010, 65 (06) : 451 - 451